INFLAMAX
Live / Allowed — Published for opposition (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jul 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98642385
- Mark type
- Stylized text
- Filed
- 10 Jul 2024
- Published for opposition
- 03 Mar 2026
- Attorney of record
- Frank W. Compagni
Goods and services
- Class 005 — Pharmaceuticals: Topical cream for pain and inflammation relief
Owner
- Xenex Laboratories Inc., Coquitlam, BC, CA
- Xenex Laboratories Inc., Coquitlam, BC, CA
Prosecution history
- 03 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Mar 2026 — PUBLISHED FOR OPPOSITION
- 25 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Jan 2026 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 24 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Jan 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 28 Aug 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 20 Aug 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 19 Feb 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 19 Feb 2025 — LETTER OF SUSPENSION E-MAILED
- 19 Feb 2025 — SUSPENSION LETTER WRITTEN
- 19 Feb 2025 — EXAMINER'S AMENDMENT ENTERED
- 19 Feb 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED